Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia
In patients with HFrEF and HK or past HK receiving suboptimal RAS inhibitor/MRA therapy, RAS inhibitor/MRA optimization increased during patiromer-facilitated run-in.
Authors
- Justin Adrian Ezekowitz (ORCID: https://orcid.org/0000-0002-2724-4086)
- Antoni Bayes-genis A (ORCID: https://orcid.org/0000-0002-3044-197X)
- Fausto José Pinto (ORCID: https://orcid.org/0000-0002-8034-4529)
- Piotr Ponikowski (ORCID: https://orcid.org/0000-0002-3391-7064)
- Jasper J. Brugts (ORCID: https://orcid.org/0000-0002-5522-9318)
- Javed Butler (ORCID: https://orcid.org/0000-0001-7683-4720)
- Gerasimos S Filippatos (ORCID: https://orcid.org/0000-0002-5640-0332)
- Matthew R. Weir (ORCID: https://orcid.org/0000-0001-8820-5702)
- Ileana L. Piña (ORCID: https://orcid.org/0000-0002-4986-7129)
- Jan Bělohlávek (ORCID: https://orcid.org/0000-0001-9455-9224)
- Andrew J.S. Coats (ORCID: https://orcid.org/0000-0002-2771-4260)
- Mikhail Kosiborod (ORCID: https://orcid.org/0000-0002-3750-9789)
- Marco Metra (ORCID: https://orcid.org/0000-0001-6691-8568)
- Tim Friede (ORCID: https://orcid.org/0000-0001-5347-7441)
- Michael Böhm
- Michele Senni (ORCID: https://orcid.org/0000-0001-5502-7882)
- Lars H. Lund (ORCID: https://orcid.org/0000-0003-1411-4482)
- Robert John Mentz (ORCID: https://orcid.org/0000-0002-3222-1719)
- Cecilia Bahit
- Sandra Waechter (ORCID: https://orcid.org/0009-0007-3338-6607)
- Patrick Rossignol (ORCID: https://orcid.org/0000-0003-4470-7932)
- Amandine Perrin
- Peter van der Meer (ORCID: https://orcid.org/0000-0002-9705-4413)
- Stefan D. Anker
- Jeffrey Budden
- Bertram Pitt
Institutions
- University of Maryland, Baltimore (US)
- University Medical Center Groningen (NL)
- Karolinska University Hospital (SE)
- Saint Luke's Health System (US)
- University of Lisbon (PT)
- University of Alberta (CA)
- Inserm (FR)
- Central Michigan University (US)
- Duke University (US)
- National and Kapodistrian University of Athens (GR)
- Charles University (CZ)
- University of Wrocław (PL)
- University of Michigan (US)
- The Heart Research Institute (AU)
- Erasmus MC (NL)
- Karolinska Institutet (SE)
- University of Mississippi (US)
- Wroclaw Medical University (PL)
- Universitätsklinikum des Saarlandes (DE)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Vifor Pharma (Switzerland) (CH)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Ospedale Papa Giovanni XXIII (IT)
- Michigan Medicine (US)
- Centro de Investigación Biomédica en Red (ES)
- Universitätsmedizin Göttingen (DE)
- Université Bourgogne Franche-Comté (FR)
- Instituto de Neurología Cognitiva (AR)
- Duke Medical Center (US)
- German Centre for Cardiovascular Research (DE)
- Saint Luke's Hospital (US)
- University General Hospital Attikon (GR)
- Centre d'Investigation Clinique Pierre Drouin (FR)
- Hospital de Santa Maria (PT)
- Duke University Hospital (US)
- Hospital Universitari Germans Trias i Pujol (ES)
- General University Hospital in Prague (CZ)
- French Clinical Research Infrastructure Network (FR)
- Vifor Pharma (United States) (US)
- Défaillance Cardiovasculaire Aiguë et Chronique
- University of Southern Mississippi (US)
- University of Milano-Bicocca (IT)
- University of Göttingen (DE)
- University of Missouri–Kansas City (US)
- Charité - Universitätsmedizin Berlin (DE)
- University of Brescia (IT)
- Universidade Nova de Lisboa (PT)
- Saarland University (DE)
Publication Details
- Journal
- Journal of the American College of Cardiology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1016/j.jacc.2024.05.079
- Citations
- 10
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.19